Your browser doesn't support javascript.
loading
Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time.
Power, Erica A; Rechberger, Julian S; Zhang, Liang; Oh, Ju-Hee; Anderson, Jacob B; Nesvick, Cody L; Ge, Jizhi; Hinchcliffe, Edward H; Elmquist, William F; Daniels, David J.
Afiliación
  • Power EA; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Rechberger JS; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Zhang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Oh JH; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Anderson JB; Brain Barriers Research Center, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
  • Nesvick CL; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Ge J; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
  • Hinchcliffe EH; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Elmquist WF; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Daniels DJ; Hormel Institute, University of Minnesota, Austin, Minnesota, USA.
Neurooncol Adv ; 5(1): vdad033, 2023.
Article en En | MEDLINE | ID: mdl-37128506
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos